Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02700880 · ClinicalTrials.gov registry record
LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry
A clinical trial, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- 250
- Enrollment target
NCT02700880: Completed study, sponsored by Zoll Medical Corporation.
NCT02700880 is a clinical trial that has completed, run by Zoll Medical Corporation. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02700880 has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The WEARIT-III registry enrolls subjects with ischemic cardiomyopathy and heart failure (including NYHA II, III, IV and an ejection fraction ≤ 35%) who wear a medically prescribed ZOLL LifeVest Wearable Defibrillator. The primary objective of the WEARIT-III Registry is to prospectively document the clinical course of high-risk cardiac patients with heart failure and ischemic cardiomyopathy prescribed with Wearable Cardioverter Defibrillator (WCD), such as left ventricular function recovery, arrhythmia, Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT), Left Ventricular Assist Device (LVAD), heart transplantation, and to assess the benefit of WCD in heart failure patients with ischemic cardiomyopathy.
Primary Outcome
The primary objective of the WEARIT-III Registry is to prospectively document the clinical course of high-risk cardiac patients with heart failure and ischemic cardiomyopathy prescribed with WCD, such as left ventricular function recovery, arrhythmia, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy (CRT), left ventricular assist device (LVAD), heart transplantation, and to assess the benefit of WCD in heart failure patients with ischemic cardiomyopathy.
Interventions
- DEVICE LifeVest
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2014-06 |
| Est. Completion | 2019-02 |
What the finished NCT02700880 record still lists
NCT02700880 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which LifeVest is the first listed.
NCT02700880 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02700880 about?
NCT02700880 is a clinical study titled "LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry". The WEARIT-III registry enrolls subjects with ischemic cardiomyopathy and heart failure (including NYHA II, III, IV and an ejection fraction ≤ 35%) who wear a medically prescribed ZOLL LifeVest Wearable Defibrillator. The primary objective of the WEARIT-III Registry is to prospectively document the ...
What is the current status of trial NCT02700880?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2014-06. Estimated completion is 2019-02.
What interventions are being tested in trial NCT02700880?
The interventions under investigation include: LifeVest (DEVICE).
Who is sponsoring clinical trial NCT02700880?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia